People: Rigel Pharmaceuticals Inc (RIGL.O)
Dr. Donald G. Payan, M.D., is Executive Vice President, President - Discovery and Research, Director of Rigel Pharmaceuticals Inc. He is one of Company's co-founders, has been a member of Company's Board since July 1996. In February 2008, Dr. Payan became Company's Executive Vice President, President of Discovery and Research. Prior to this role, he served as Company's Executive Vice President and Chief Scientific Officer since January 1997. From January 1997 to July 1998, he also served as Company's Chief Operating Officer. From July 1996 to January 1997, Dr. Payan served as Company's President and Chief Executive Officer. The Board concluded that Dr. Payan should continue to serve as a member of the Board in part due to the fact that he brings historic knowledge and continuity to the Board as one of Company's co-founders, as well as research experience and demonstrated ability to grow new research programs. From December 1995 to May 1996, Dr. Payan was Vice President of AxyS Pharmaceuticals, Inc., a biopharmaceutical company. From September 1992 to December 1995, Dr. Payan was Executive Vice President and Chief Scientific Officer of Khepri Pharmaceuticals, Inc., a biopharmaceutical company, which he founded and subsequently merged with AxyS Pharmaceuticals. Dr. Payan did his residency training in Medicine at Massachusetts General Hospital and is a former Professor of the University of California, San Francisco and member of The Howard Hughes Medical Institute.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|